This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Non-Hodgkin lymphoma
  • /
  • ESMO Consensus Conference on Malignant Lymphoma: G...
Guideline

ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia

Read time: 1 mins
Last updated:1st Dec 2016
ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia - European Society for Medical Oncology (ESMO)


In order to complement the already available European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with malignant lymphomas, ESMO organised a consensus conference on mature B-cell lymphomas and chronic lymphocytic leukaemia to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (i) the elderly patient, (ii) prognostic factors suitable for clinical use and (iii) the ‘ultra-high-risk’ group.

This manuscript presents recommendations on prognostic factors suitable for clinical use and focuses on the three less common lymphoproliferative malignancies: marginal zone lymphoma, mantle cell lymphoma and peripheral T-cell lymphomas.

 

Read full guideline